Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Opioid Litigation topic
No spam. Unsubscribe anytime.
Board moves into closed session on opioid litigation, authorizes settlement participation
Summary
Douglas County moved into closed session under Minnesota Statutes Section 13D.05, Subd. 3(b) to discuss opioid litigation against multiple manufacturers, then authorized the County Attorney to sign and submit an Opioid Settlement Participation Form.
At 9:52 a.m. on Sept. 16 the Douglas County Board entered closed session under Minnesota Statutes Section 13D.05, Subd. 3(b) to discuss opioid litigation involving manufacturers including Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sandoz, Sun and Zydus. Commissioners Tim Kalina, Charlie Meyer, Shane Schmidt and Jeff Way and County Attorney Chad Larson attended the closed session.
The board exited closed session at 9:59 a.m. and subsequently authorized the County Attorney to sign and submit an Opioid Settlement Participation Form to the settlement administrator. The authorization passed unanimously among the four attending commissioners; Jerry L. Rapp was recorded absent.
The minutes do not record detailed discussion points from the closed session. The board cited Minnesota statutory authority permitting the closed-session discussion of active litigation.
